The global Agentive AI in Healthcare Market was valued at USD 538.56 million in 2024 and is projected to reach USD 10,857.16 million by 2032, growing at a CAGR of 45.58% over 2025–2032. The U.S. led the market with a valuation of USD 200.22 million in 2024 and is expected to achieve USD 3957.44 million by 2032. Accelerated integration of multi-agent frameworks, deployment of smart virtual assistants, and the expansion of AI-driven remote patient monitoring are reshaping healthcare operations globally. Increased need for automation, workflow optimization, and intelligent decision support are fueling demand for agentive AI platforms across hospitals, payers, and telehealth ecosystems.

In terms of segmentation, single-agent systems accounted for the largest share of the agentic AI in healthcare market in 2024 at 47.2%, while pre-built agentic AI solutions were the leading segment in the product market during 2024 with 52.5% share. Machine learning captured 38.1% of the agentive AI in healthcare market share in 2024, with smart virtual assistants (SVAs) being the high-growth category within technology. Medical imaging & diagnostics continued to be the leading application segment in 2024, accounting for 29.4% of the total market.

The agentic AI in healthcare market in North America is dominant, contributing more than 41.3% of the global revenue, while Asia Pacific is the fastest-growing region capturing 20.6% of the market share in 2024. Europe captured 25.7% of the market in 2024, supported by strong government-backed digital health initiatives and the integration of AI under GDPR-compliant frameworks. Germany is leading hospital digitization under the DiGA framework, while France and the UK focus on expanding agentic systems in diagnostics and hospital management. Major players in the Agentive AI In Healthcare Market include NVIDIA, Oracle, Microsoft, and more. The market is segmented by agent system type, product type, technology, application, and end-use. Recent developments include Microsoft’s MAI‑DxO achieving 85.5% accuracy in diagnosing complex cases and IQVIA using NVIDIA tech to streamline clinical trial workflows. The market size is projected to reach USD 10.857 billion by 2032, with a CAGR of 45.58% from 2025 to 2032. SNS Insider offers comprehensive analysis and insights on the Agentive AI In Healthcare Market.

Read more at GlobeNewswire: Agentive AI in Healthcare Market Set to Surpass USD 10.86